We've detected an Ad Blocker in your browser.
Please disable or pause the Ad Blocker and refresh the page to be able to register and access the website normally.
4–6 MAY 2022
15:00–20:00 CEST | 9:00–14:00 EDT
Day 1: Individualising Treatment
Day 2: Complex Phenotypes and Advanced Treatment
Day 3: Beyond Foundational Management
Brought to you by:
A global virtual event dedicated to the latest heart failure treatment strategies to support better patient outcomes
Overview
Radcliffe Cardiology is delighted to introduce Heart Failure Online (HFO) from 4–6 May 2022 at 15:00–20:00 CEST / 9:00–14:00 EDT.
Heart Failure Online (HFO) is a new innovative virtual event, that will bring together a leading international faculty to create a rich, interactive experience to best inform the global heart failure community of the latest developments and advances in clinical practice.
With patient management and outcomes at its core, Course Director Prof Andrew Coats (President of the Heart Failure Association and Professor of Cardiology, University of Warwick, UK) will lead an interactive programme of discussion, opinion and case studies focusing on the patient journey. By utilising a key theme each day, this event will enable multiple aspects of the HF management to be explored by a global faculty, delivering 9 hours of best-in-class learning.
An innovative three-day event:
- Expert opinion and discussion from international thought-leaders
- Case studies
- Audience interaction
- Best-in-class learning
- Global faculty
- 9-hours of CME-accredited learning*
Heart Failure Online 2022 has been accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 9 CME points, equating to 9 hours of learning. Physicians may convert EBAC External CME credits to AMA PRA Category 1 CreditsTM
Share this event:
COURSE DIRECTOR
Prof Andrew Coats
Programme
(Please note this programme is subject to change)
DAY 1: Individualising Treatment
4 May | 15:00 - 19:00 CEST / 9:00 - 13:00 EDT
Presentation and Discussion
15:20 CEST- EF – What’s in a Name? A Debate Considering the Importance of EF in Treatment Selection
- HFpEF: Is it Still the Problem Child it Once Was?
- Hot topic: Advances in Comorbidity Management in HF Management
- Lifetime Management of HFpEF
- Heart Failure With Preserved Ejection Fraction and Tricuspid Regurgitation - Partners in Crime!
- Coordinating the MDT in Discharge Planning
- Advances in Digital Healthcare and Using it in Daily Practice: Remote Monitoring in Heart Failure
- Hot Topic: Update in Telemonitoring – Where Does it Fit in Today’s Practice?
Patient Case Presentation and Panel Discussion
15:00 CEST- The Complex Patient
- Transitioning Care and Monitoring Technology
Symposia Sessions
16:30 CEST- The 2022 ACC Heart Failure Guidelines: What Do They Mean for Your Practice?
WATCH ON-DEMAND
DAY 2: Complex Phenotypes and Advanced Treatment
5 May | 15:00 - 20:00 CEST / 9:00 - 14:00 EDT
Presentation and Discussion
16:20 CEST- Knowing When to Treat the Underlying Cause of HF: Aetiology Essentials
- Advances in Non-cardiac Comorbidity Management with Focus on Hyperkalaemia
- Functional MR in Heart Failure
- Triaging of Patients with Advanced Heart Failure: Mechanical Assistance or Transplant? A US vs European View
- MCS Considerations: Compliance and Psychosocial Support
- Cardiopulmonary Exercise Testing in Advanced Patients
- Improving Outcomes Post-transplantation
Patient Case Presentation and Panel Discussion
15:00 CEST- HF Aetiology
- Advanced HF care
Live Case
15:20 CEST- MitraClip Case - Heart Centre, Mainz, DE
WATCH ON-DEMAND
DAY 3: Beyond Foundational Management
6 May | 15:00 - 18:30 CEST / 9:00 - 12:30 EDT
Presentation and Discussion
15:30 CEST- Quality of Life: What is it and Should There be More Emphasis QoL Outcomes in Clinical Trials?
- Clinical Interventions to Improve Functional Capacity and QoL
- The Future of ICD use in Ischaemic and Non-ischaemic HF
- Spotlight Session: The Changing Role of the Heart Team: What is the Future?
Patient Case Presentation and Panel Discussion
15:00 CEST- Quality of Life and Multi-Disciplinary Care in HF
Live Case
16:45 CEST- CRT Case - Barts Heart Centre, London, UK
Symposia Sessions
17:40 CEST- Making Gains in HFpEF: An Appraisal of Where We Are Now
WATCH ON-DEMAND
Course Leadership
Prof Andrew Coats
COURSE DIRECTOR
University of Warwick, UK
Prof Coats is Joint Academic Vice-President of Monash University, Australia and the University of Warwick, UK. His research greatly influenced the treatment for chronic heart failure, promoting exercise training instead of bed rest. He has a vast experience in education and publishing.
Prof Coats attended Melbourne Grammar School and studied at Oxford and Cambridge. He has a higher doctorates from Oxford (DM) and Imperial (DSc.).
Prof Coats was appointed Viscount Royston Professor of Cardiology at Imperial College in 1996 and Director of Cardiology and Associate Medical Director of the Royal Brompton and Harefield NHS trust. Professor Coats was appointed Dean of Medicine at the University of Sydney in 2002, and subsequently Deputy Vice-Chancellor. Professor Coats was most recently CEO of the Norwich Research Park, the UK's oldest and largest research and innovation park.
Prof Coats research interests are chronic heart failure, hypertension, and organizational behaviour. Professor Coats has a MBA from London Business School, is a Diplomate and Fellow of the Australian Institute of Company Directors and member of the UK Institute of Directors.
More info 
Less info
Dr Ileana Piña
COURSE CO-DIRECTOR
Wayne State University, Detroit, MI, US
Ileana L Pina, MD, MPH, is Professor, Department of Medicine (Cardiology) and Professor, Department of Epidemiology and Population Health - Montefiore Einstein Center for Heart and Vascular Care, US.
Dr Piña has a particular research and clinical interest in rehabilitation of heart disease in patients with heart failure. She completed a NHLBI HF ACTION trial and is in the process of examining recovery after exercise which could be translated to an additional parameter that may better predict prognosis of outcomes. In addition, there was a R21 to NHLBI to examine Vitamin D levels as another predictor from the HF ACTION database.
Dr Piña was appointed Director of Heart Failure and Transplantation at University Hospitals of Cleveland, a position she held from 1999 to 2006. She further completed a Quality Scholar Fellowship at the Cleveland Louis Stokes Veterans’ Administration Medical Center. In July 2011, she joined the Montefiore Einstein Center for Heart and Vascular Care as Associate Chief for Academic Affairs and Staff Physician.
Dr Ileana L Pina is an Editorial Board member of Cardiac Failure Review.
More info
Less info
Dr Shelley Zieroth
COURSE CO-DIRECTOR
University of Manitoba, CA
Dr Shelley Zieroth is currently at SBH Heart Failure and Transplant Clinics and serves as Head of the Medical Heart Failure Program, WRHA Cardiac Sciences Program, and as Associate Professor of the Section of Cardiology at the University of Manitoba, Canada.
Dr Shelley Zieroth is an Editorial Board member of Cardiac Failure Review.
More info
Less info
Faculty
Dr Biykem Bozkurt
Texas, US
Dr Javed Butler
Mississippi, US
Prof Martin Cowie
London, UK
Dr Shelley Hall
Dallas, US
Dr Loreena Hill
Belfast, UK
Prof Richard Hobbs
Oxford, UK
Prof Ewa Jankowska
Wroclaw, PL
Dr Mikhail Kosiborod
Kansas, US
Prof Carolyn Lam
Singapore, SG
Dr Maria Crespo Leiro
Coruña, ES
Prof Cecilia Linde
Stockholm, SE
Prof Phillip Lurz
Leipzig, DE
Dr Alanna Morris
Georgia, US
Prof Massimo Piepoli
Piacenza, IT
Dr Fabien Praz
Bern, CH
Dr Rajiv Sankaranarayanan
Liverpool, UK
Dr Harriette Van Spall
Hamilton, CA
Dr Joyce Wald
Philadelphia, US
WATCH ON-DEMAND
Target Audience
- Heart Failure Specialists
- General Cardiologists
- General Practitioners (GPs)
- Nurses, Pharmacists, and other Allied Healthcare Professionals
Learning Objectives
Following the activities, participants will be able to:
- Select foundational and advanced management strategies in complex patients
- Discuss the validity of using ejection fraction to determine optimal treatment strategies
- Assess the likely impact of health technology on future practice
- Identify the underlying causes of heart failure
- Select appropriate interventional and device-based treatments for treating underlying causes of heart failure
- Assess the impact of the multidisciplinary team on heart failure outcomes
- Discuss the importance of using quality of life and patient self-assessed measures relative to hard clinical end points
Educational Partners:
If you’re interested in becoming an educational partner or sponsor at HFO, please contact sales@radcliffe-group.com
Official Journal
Cardiac Failure Review (CFR) is an international, English language, peer-reviewed journal that publishes articles continually to CFRjournal.com and aims to assist time-pressured physicians to stay abreast of key advances and opinion in the area of heart failure.
The journal comprises balanced and comprehensive review articles written by leading authorities. The journal provides updates on a range of salient issues to support physicians in developing their knowledge and effectiveness in day-to-day clinical practice.
The journal endeavours to support the continuous medical education of specialist and general cardiologists and disseminate knowledge of the field to the wider cardiovascular community.
Led by Editor-in-Chief, Prof Andrew Coats, along with Deputy Editor in Chief, Giuseppe Rosano and Associate Editor Christiana Vitale and an editorial board of world-renowned physicians, the Journal publishes peer-reviewed articles that aim to provide timely updates on the most pertinent issues in the field.
View the latest volume of CFR.
About Radcliffe Cardiology
We are Radcliffe, a knowledge network for the cardiovascular community.
We’re here to bring cardiovascular knowledge, insight and innovation to life for clinicians around the world, using our communications and creative expertise, our platforms and connections across the community to help transform theory into practice faster and more effectively.
We bring medical knowledge to life
From great science writing and smart journal editing, the curation of evidence based and peer-reviewed content, to engaging new formats that cut through the noise, we believe that communication is at the heart of great healthcare.
Our work is underpinned by 3 core principles:
- We build on the best science
- We work hands-on with our community
- We bring fresh thinking
Our promise is that we’ll equip you with the latest knowledge and skills you need, to do the best for your patients.
For more information on Radcliffe Cardiology, please visit www.radcliffecardiology.com.